Answer
Moclobemide inhibits CYP2C19 and can increase omeprazole concentrations, with a doubling of omeprazole exposure in CYP2C19 extensive metabolisers; caution is needed with concomitant use.
Sources for this answer
- Manerix 300mgViatris (formerly Mylan or Upjohn) · emc · SmPC §4.5 Interaction with other medicinal products · Version 10Document updated
Sources checked